IO Biotech, Inc.

IOBT · Nasdaq · SIC 2834: Pharmaceutical Preparations
83
SEC Filings

Business Summary

6 Item 1A. Risk Factors 67 Item 1B. Unresolved Staff Comments 124 Item 1C. Cybersecurity Risk Management, Strategy and Governance 124 Item 2. Properties 124 Item 3. Legal Proceedings 125 Item 4. Mine Safety Disclosures 125 PART II 126 Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 126 Item 6. (Reserved) 127 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 128 Item 7A. Quantitative and...

Next Earnings

Q2 FY2026 — expected 2026-09-17

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionIOBTdiscussed_in_filing Cybersecurity
topic_mentionIOBTdiscussed_in_filing Cybersecurity
topic_mentionIOBTdiscussed_in_filing Cybersecurity
topic_mentionIOBTdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-03-312024-12-310000950170-25-047744EDGAR114K words
2024-03-052023-12-310000950170-24-026275EDGAR—
2023-03-142022-12-310000950170-23-007902EDGAR—
2022-03-312021-12-310000950170-22-005244EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-142025-09-300001193125-25-281820EDGAR76K words
2025-08-142025-06-300001193125-25-180860EDGAR—
2025-05-142025-03-310000950170-25-070956EDGAR—
2024-11-122024-09-300000950170-24-125524EDGAR—
2024-08-132024-06-300000950170-24-096168EDGAR—
2024-05-142024-03-310000950170-24-059108EDGAR—
2023-11-132023-09-300000950170-23-062963EDGAR—
2023-08-112023-06-300000950170-23-041620EDGAR—
2023-05-112023-03-310000950170-23-021288EDGAR—
2022-11-092022-09-300000950170-22-023876EDGAR—
2022-08-112022-06-300000950170-22-016919EDGAR—
2022-05-162022-03-310000950170-22-010101EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-310001193125-26-133331EDGAR1K words
2026-02-130001193125-26-051790EDGAR—
2026-01-300001193125-26-031987EDGAR—
2026-01-210001193125-26-017164EDGAR—
2025-12-190001193125-25-327089EDGAR—
2025-11-210001193125-25-291504EDGAR—
2025-11-180001193125-25-285282EDGAR—
2025-11-140001193125-25-281657EDGAR—
2025-09-290001193125-25-221704EDGAR—
2025-08-140001193125-25-180830EDGAR—

83 total filings indexed. 57 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001865494
TickerIOBT
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 67afcb7c9c8567c96b6f7eca032f09e52e4e50490807734c627e9132494e16a9
parent: efc7ddc4643d02763ccbb2d8e4d7a1e5c4cf5441f8a9668d5f784649a45f340f
content hash: c191d235bf46bbeff49261194b05cbab8e6b8fc82b539655ee3bcf3bc83b60bd
signed: 2026-04-13T04:45:43.510Z
sources: 16 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf